Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127817081 | 12781708 | 1 | I | 201411 | 20160915 | 20160926 | 20160926 | EXP | BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-61046BR | BOEHRINGER INGELHEIM | 76.49 | YR | F | Y | 64.00000 | KG | 20160926 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127817081 | 12781708 | 1 | PS | MICARDIS | TELMISARTAN | 1 | Oral | 80 MG | 508065 | 20850 | 80 | MG | TABLET | QD | |||||
| 127817081 | 12781708 | 2 | C | HIGROTON | CHLORTHALIDONE | 1 | Oral | 25 MG | 0 | 25 | MG | TABLET | QD | ||||||
| 127817081 | 12781708 | 3 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 5 MG | 0 | 5 | MG | TABLET | QD | ||||||
| 127817081 | 12781708 | 4 | C | ZETIA | EZETIMIBE | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 127817081 | 12781708 | 5 | C | CONCOR | BISOPROLOL FUMARATE | 1 | Oral | 2.5 MG | 0 | 2.5 | MG | TABLET | QD | ||||||
| 127817081 | 12781708 | 6 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG | 0 | 75 | MG | TABLET | QD | ||||||
| 127817081 | 12781708 | 7 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
| 127817081 | 12781708 | 8 | C | SYSTANE UL | 2 | Intraocular | 2 ANZ | 0 | ORAL DROPS | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127817081 | 12781708 | 1 | Hypertension |
| 127817081 | 12781708 | 2 | Hypertension |
| 127817081 | 12781708 | 3 | Blood triglycerides increased |
| 127817081 | 12781708 | 4 | Blood triglycerides increased |
| 127817081 | 12781708 | 5 | Heart rate increased |
| 127817081 | 12781708 | 6 | Ischaemia |
| 127817081 | 12781708 | 7 | Gastritis |
| 127817081 | 12781708 | 8 | Cataract |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127817081 | 12781708 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127817081 | 12781708 | Back pain | |
| 127817081 | 12781708 | Cerebrovascular accident | |
| 127817081 | 12781708 | Chest pain | |
| 127817081 | 12781708 | Coccydynia | |
| 127817081 | 12781708 | Myalgia | |
| 127817081 | 12781708 | Neck pain | |
| 127817081 | 12781708 | Pain in extremity | |
| 127817081 | 12781708 | Paraesthesia | |
| 127817081 | 12781708 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127817081 | 12781708 | 2 | 2011 | 0 | ||
| 127817081 | 12781708 | 3 | 2011 | 0 | ||
| 127817081 | 12781708 | 4 | 2011 | 0 | ||
| 127817081 | 12781708 | 5 | 201405 | 0 | ||
| 127817081 | 12781708 | 6 | 201405 | 0 | ||
| 127817081 | 12781708 | 7 | 2011 | 0 | ||
| 127817081 | 12781708 | 8 | 2011 | 0 |